In this page special characters are used as Footnotes reference and respective footnotes are present at the end of the main landmark
“Wondering aboutthe cost of MAVYRET?”
– James, CURED* with MAVYRET
– James, CURED* with MAVYRET
MAVYRET LIST PRICE
The list price, also known as the Wholesale Acquisition Cost (WAC), for one month of MAVYRET, is $13,200.00 as of January 2023. The WAC may not reflect the price paid by patients.
to find out how much MAVYRET will cost for you.
|If you have:||You could pay:|
$20.00 or less per month, depending on state plan
|Commercial Insurance (usually provided by employer)
(Blue Cross Blue Shield, Aetna, etc)
As little as $5 a month with MAVYRET Savings Card
|Medicare: Part D||
$660.00-3,204.00 per month, depending on coverage phase
Monthly out-of-pocket cost for MAVYRET may vary depending on patient’s other medication costs.
Most Medicare patients have Standard Part D prescription coverage, which has different costs depending on deductibles and coverage gaps. An Insurance Specialist can help you understand what these costs mean to you, by calling 1-877-628-9738.
$10.35 per month starting January 1, 2023
|Uninsured or having difficulty paying for your medication|
|Other Insurance (VA,
DoD, TRICARE, others)
Because coverage varies by plan, call 1-877-628-9738 to speak to an Insurance Specialist to find out how much MAVYRET will cost you.
†Terms and Conditions apply. This benefit covers MAVYRET® (glecaprevir/pibrentasvir). Eligibility: Available to patients with commercial insurance coverage for MAVYRET who meet eligibility criteria. Co-pay assistance program is not available to patients receiving reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the MAVYRET co-pay card and patient must call MAVYRET Patient Support at 1-877-628-9738 to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from MAVYRET Patient Support from any third-party payers. Offer subject to change or discontinuation without notice. Restrictions, including monthly maximums, may apply. Subject to all other terms and conditions, the maximum lifetime benefit that may be available solely for the patient’s benefit under the co-pay assistance program is $12,000.00. The actual application and use of the benefit available under the co-pay assistance program may vary on a monthly, quarterly, and/or annual basis, depending on each individual patient’s plan of insurance and other prescription drug costs. This assistance offer is not health insurance. By redeeming this card, you acknowledge that you are an eligible patient and that you understand and agree to comply with the terms and conditions of this offer. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy
If you are having difficulty paying for your medicine, myAbbVie Assist may be able to help.
myAbbVie Assist, our patient assistance program, provides AbbVie medicine to qualifying patients. It is intended for people that live in the United States, have limited or no health insurance coverage and demonstrate qualifying financial need.
to learn more.